GLYCEROL PHENYLBUTYRATE - glycerol phenylbutyrate liquid
Lupin Pharmaceuticals, Inc.
----------
| MEDICATION GUIDE
Glycerol Phenylbutyrate (GLIS-er-ol FEN-il-BUE-ti-rate) Oral Liquid What is the most important information I should know about Glycerol Phenylbutyrate Oral Liquid? Glycerol phenylbutyrate oral liquid may cause serious side effects, including: Nervous system problems (Neurotoxicity). Phenylacetate (PAA), a breakdown product of glycerol phenylbutyrate oral liquid, may cause nervous system side effects. Call your doctor or get medical help right away if you get any of these symptoms while taking glycerol phenylbutyrate oral liquid: |
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
| Your doctor may do blood tests to measure the amount of PAA in your blood during your treatment with glycerol phenylbutyrate oral liquid. |
||
What is Glycerol Phenylbutyrate Oral Liquid?
|
||
Before taking glycerol phenylbutyrate oral liquid, tell your doctor about all of your medical conditions, including if you:
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, dietary and herbal supplements. Know the medicines you take. Keep a list of them to show your doctor and pharmacist when you get a new medicine. |
||
How should I take Glycerol Phenylbutyrate Oral Liquid?
o Open the glycerol phenylbutyrate oral liquid bottle and twist on the new reclosable bottle cap adapter. o Use a new dry oral syringe to remove each prescribed dose of glycerol phenylbutyrate oral liquid. o Throw away (discard) the oral syringe after each dose. o Tightly close the tethered tab on the reclosable bottle cap adapter after each use. o Do not rinse the reclosable bottle cap adapter. o If water or moisture enters the glycerol phenylbutyrate oral liquid bottle, the contents will become cloudy in appearance. If the contents appear cloudy at any time, do not use the remaining glycerol phenylbutyrate oral liquid and return the bottle to your pharmacy to throw it away. o Throw away the bottle and any unused glycerol phenylbutyrate oral liquid 28 days after opening.
|
||
For people who cannot swallow and who have a nasogastric or gastrostomy tube in place, glycerol phenylbutyrate oral liquid should be given as follows:
|
||
| What are the possible side effects of Glycerol Phenylbutyrate Oral Liquid?
Glycerol phenylbutyrate oral liquid may cause serious side effects, including:
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The most common side effects of glycerol phenylbutyrate oral liquid in children 2 months to less than 2 years of age include:
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| The most common side effects of glycerol phenylbutyrate oral liquid in children less than 2 months of age include:
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| These are not all of the possible side effects of glycerol phenylbutyrate oral liquid. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. |
||
| How should I store Glycerol Phenylbutyrate Oral Liquid?
Store glycerol phenylbutyrate oral liquid between 68ºF to 77ºF (20°C to 25°C). Keep glycerol phenylbutyrate oral liquid and all medicines out of the reach of children. |
||
| General information about the safe and effective use of glycerol phenylbutyrate oral liquid
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use glycerol phenylbutyrate oral liquid for a condition for which it was not prescribed. Do not give glycerol phenylbutyrate oral liquid to other people, even if they have the same symptoms you have. It may harm them. You can ask your doctor or pharmacist for information about glycerol phenylbutyrate oral liquid that is written for health professionals. |
||
| What are the ingredients in Glycerol Phenylbutyrate Oral Liquid?
Active ingredient: glycerol phenylbutyrate |
||
| For more information call 1-800-772-6436. Manufactured for: Lupin Pharmaceuticals, Inc. Naples, FL 34108 United States |
||
This Medication Guide has been approved by the U.S. Food and Drug Administration.
Revised: May 2025 ID # PC5995